Related Experiment Video
Updated: May 3, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 15, 2016
Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice
Kirsten L Rose1, Danielle Paixao-Cavalcante, Jennifer Fish
1Molecular Genetics and Rheumatology Section, Faculty of Medicine, Imperial College, Hammersmith Campus, London, United Kingdom.
Abstract:
The inflammatory kidney disease membranoproliferative glomerulonephritis type II (MPGN2) is associated with dysregulation of the alternative pathway of complement activation. MPGN2 is characterized by the presence of complement C3 along the glomerular basement membrane (GBM). Spontaneous activation of C3 through the alternative pathway is regulated by 2 plasma proteins, factor H and factor I. Deficiency of either of these regulators results in uncontrolled C3 activation, although the breakdown of activated C3 is dependent on factor I. Deficiency of factor H, but not factor I, is associated with MPGN2 in humans, pigs, and mice. To explain this discordance, mice with single or combined deficiencies of these factors were studied. MPGN2 did not develop in mice with combined factor H and I deficiency or in mice deficient in factor I alone. However, administration of a source of factor I to mice with combined factor H and factor I deficiency triggered both activated C3 fragments in plasma and GBM C3 deposition. Mouse renal transplant studies demonstrated that C3 deposited along the GBM was derived from plasma. Together, these findings provide what we believe to be the first evidence that factor I-mediated generation of activated C3 fragments in the circulation is a critical determinant for the development of MPGN2 associated with factor H deficiency.
Insights
Factor I is crucial for developing membranoproliferative glomerulonephritis type II (MPGN2) in factor H-deficient individuals. This kidney disease involves complement C3 deposition, and factor I drives its formation in the circulation.
Area of Science:
- Nephrology
- Immunology
- Complement System Biology
Background:
- Membranoproliferative glomerulonephritis type II (MPGN2) is an inflammatory kidney disease linked to complement alternative pathway dysregulation.
- MPGN2 features complement C3 deposition along the glomerular basement membrane (GBM).
- Factor H and Factor I are key regulators of C3 spontaneous activation via the alternative pathway.
Purpose of the Study:
- To investigate the discordance in MPGN2 development between factor H and factor I deficiencies.
- To elucidate the role of factor I in C3 deposition and MPGN2 pathogenesis.
Main Methods:
- Studied mice with single or combined deficiencies of factor H and factor I.
- Administered factor I to mice with combined factor H and I deficiency.
- Utilized mouse renal transplant models to trace C3 deposition origins.
Main Results:
- MPGN2 did not develop in mice deficient in factor I alone or in combined factor H and I deficiency.
- Factor I administration to factor H/I deficient mice induced plasma C3 fragments and GBM C3 deposition.
- Renal transplant studies confirmed plasma origin of GBM-deposited C3.
Conclusions:
- Factor I-mediated generation of activated C3 fragments in circulation is critical for MPGN2 development in factor H deficiency.
- This study provides the first evidence linking factor I activity to MPGN2 pathogenesis in factor H deficiency.

